Theranos CEO Focuses On Future, Reveals Plans For Blood-Testing ‘MiniLab’
Elizabeth Holmes spoke about the scandal-plagued company's technology on Monday at the annual meeting of the American Association for Clinical Chemistry.
The Wall Street Journal:
Theranos Makes Case To Laboratory Experts
Theranos Inc. founder Elizabeth Holmes announced a new blood-testing device at an academic conference here Monday but didn’t address problems found with the company’s earlier machines. At the annual meeting of the American Association for Clinical Chemistry, a group of laboratory scientists, Ms. Holmes described a device, called miniLab, resembling a computer printer. Theranos says it can run tests accurately on as little as 160 microliters of blood, or a few drops, pricked from a finger. (Carreyrou, 8/1)
San Francisco Business Times:
Theranos Unveils New Product, Little Data On Existing Tech
Theranos Inc. unveiled a new blood-testing device at a conference in Philadelphia, where it had been expected Monday to provide data that showed its existing, controversial technology worked. The Palo Alto company, whose founder and CEO Elizabeth Holmes faces a two-year ban from the blood-testing industry, presented a “miniLab” blood-testing device that analyzes blood drawn in the traditional way instead of the small finger-prick samples its previous tech was based on. (Schubarth, 8/1)
Mercury News:
Long-Awaited Theranos Presentation Leaves Questions About Blood Tests
Holmes took the stage at the American Association for Clinical Chemistry’s meeting in Philadelphia as she faces a two-year ban from the blood testing industry and intense scrutiny over her company’s technology. On Monday she spoke about a new blood testing machine that is removed from that crisis — the miniLab. And she revealed a new test the company had developed to diagnose the Zika virus. (Kendall, 8/1)